KC
BIIB icon

Kepos Capital’s Biogen BIIB Stock Holding History

Kepos Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,788
Closed -$1.12M – 186
2019
Q4 		$1.12M Buy
+3,788
New +$1.05M 0.11% 103
2019
Q2 		– Sell
-25,761
Closed -$6.09M – 312
2019
Q1 		$6.09M Buy
25,761
+5,097
+25% +$1.6M 0.46% 56
2018
Q4 		$6.22M Buy
20,664
+1,697
+9% +$542K 0.48% 53
2018
Q3 		$6.7M Sell
18,967
-1,578
-8% -$543K 0.34% 50
2018
Q2 		$5.96M Buy
20,545
+2,681
+15% +$754K 0.3% 72
2018
Q1 		$4.89M Buy
17,864
+2,997
+20% +$930K 0.29% 72
2017
Q4 		$4.74M Buy
14,867
+5,615
+61% +$1.8M 0.43% 37
2017
Q3 		$2.9M Buy
+9,252
New +$2.74M 0.48% 29

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Kepos Capital's BIIB Position: Q1 2020 in Review

Kepos Capital sold out of Biogen (BIIB) in Q1 2020, closing a stake of 3,788 shares — an estimated $1.12M sold.

Kepos Capital first reported a position in BIIB in Q3 2017 and held it in 8 quarters. The position peaked at $6.7M in Q3 2018. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q1 2020.

  • Kepos Capital reported no remaining Biogen position as of Q1 2020 after selling out during the quarter.
  • Kepos Capital sold 3,788 Biogen shares in Q1 2020, an estimated $1.12M.
  • Kepos Capital first reported a position in Biogen in Q3 2017 and held it in 8 quarters.
  • Kepos Capital's Biogen position peaked at $6.7M in Q3 2018.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q1 2020.

Based on Kepos Capital's 13F filing for Q1 2020, filed 12 May 2020.